UBS’s Adtran ADTN Stock Holding History

UBS’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-300	Closed	-$8K	–	10342
2013 Q3	$8K	Buy	+300	New	+$7.78K	﹤0.01%	8993

Other funds holding ADTN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

UBS's ADTN Position: Q3 2014 in Review

UBS reduced its Adtran (ADTN) stake by 85% in Q3 2014, selling an estimated $6.45K and leaving 52 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10128.

UBS first reported a position in ADTN in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.64M in Q1 2014. 147 funds tracked by Wall St. Rank hold ADTN as of Q3 2014.

UBS held 52 shares of Adtran worth $1K as of Q3 2014.
UBS sold 288 Adtran shares in Q3 2014, an estimated $6.45K.
Adtran made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10128 holding.
UBS first reported a position in Adtran in Q2 2013 and has held it in 6 quarters since.
UBS's Adtran position peaked at $2.64M in Q1 2014.
147 funds tracked by Wall St. Rank held Adtran as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.